The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
The first cross-class combination NRTI combinations have greatly improved patient adherence to therapy, but as they must still be combined with drugs ... for example, a product combining the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results